Updating results

223 results

Sort: Relevance | Date

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (MIB137)

Advice on the use of plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published January 2018

Health app: GDm-Health for people with gestational diabetes (MIB131)

Advice on the GDm-Health app to remotely monitor blood glucose in people with gestational diabetes (diabetes in pregnancy) to aid local decision-making

Medtech innovation briefing Published November 2017

Fungitell for antifungal treatment stratification (MIB118)

Advice on the use of the Fungitell assay for detecting fungal infections (pathogens, fungus, fungi) in guiding antifungal treatment to aid local decision-making

Medtech innovation briefing Published August 2017

The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24)

Advice on the use of the OraQuick HCV point-of-care test for rapid detection of hepatitis C virus antibodies to aid local decision-making

Medtech innovation briefing Published March 2015

S-Cath System for suprapubic catheterisation (MIB68)

Advice on the use of the S-Cath System for suprapubic catheterisation to aid local decision-making

Medtech innovation briefing Published June 2016

Multidrug resistant urinary tract infections: fosfomycin trometamol (ESUOM17)

This evidence summary has been withdrawn because a product containing fosfomycin trometamol with a marketing authorisation for treating multidrug resistant urinary tract infections is now available in the UK.

Evidence summary Published July 2013

The Prosigna gene expression profiling assay for assessing long‑term risk of breast cancer recurrence (MIB27)

This guidance has been updated and replaced by NICE diagnostics guidance 34.

Medtech innovation briefing Published March 2015

The ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia (MIB20)

This advice has been updated and replaced by NICE diagnostics guidance 32.

Medtech innovation briefing Published February 2015

DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)

We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.

Medtech innovation briefing Published November 2019

PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)

This advice has been updated and replaced by NICE medical technologies guidance 43.

Medtech innovation briefing Published June 2018

Point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145)

This advice has been updated and replaced by NICE diagnostics guidance 38.

Medtech innovation briefing Published May 2018

Curos disinfecting cap for needleless connectors (MIB143)

This advice has been updated and replaced by NICE medical technologies guidance 44.

Medtech innovation briefing Published April 2018

Eyemax mono for age-related macular degeneration (MIB154)

We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.

Medtech innovation briefing Published August 2018

Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

This advice has been replaced by NICE diagnostics guidance 37.

Medtech innovation briefing Published January 2018

Mepilex Border dressings for preventing pressure ulcers (MIB124)

This advice has been updated and replaced by NICE medical technologies guidance 40.

Medtech innovation briefing Published October 2017

EndoPredict gene expression profiling assay for assessing risk of breast cancer recurrence (MIB44)

This guidance has been updated and replaced by NICE diagnostics guidance 34.

Medtech innovation briefing Published November 2015

The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)

This guidance has been updated and replaced by NICE diagnostics guidance 29.

Medtech innovation briefing Published October 2015

Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

Medtech innovation briefing Published October 2016

UrgoStart for chronic wounds (MIB82)

This advice has been updated and replaced by NICE medical technologies guidance 42.

Medtech innovation briefing Published October 2016

Ultroid 2.0 for internal haemorrhoids (MIB75)

This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.

Medtech innovation briefing Published July 2016

Lutonix drug-coated balloon for peripheral arterial disease (MIB72)

NICE withdrew this medtech innovation briefing in October 2019 after the MHRA withdrew support for this type of technology being used in intermittent claudication for arterial disease.

Medtech innovation briefing Published July 2016

Promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126)

This advice has been replaced by NICE diagnostics guidance 36.

Medtech innovation briefing Published October 2017